Dr. Kimberly Smith, a renowned US infectious disease specialist, and Head of Research & Development for ViiV Healthcare, joins Ben on the podcast to talk about new data on cabotegravir as potential long-acting injectable HIV prevention technology, as well as new approaches to treat HIV with next generation medicines. She shares how she has led a global R&D operation in the era COVID-19 and what Black Lives Matters means to her as a leading African American clinician and pharmaceutical leader.
For more information:
https://viivhealthcare.com
https://bayareaglobalhealth.org
https://www.aids2020.org
https://coronavirus.ucsf.edu
https://www.who.int
https://www.cdc.gov
https://www.nih.gov
www.ashotinthearmpodcast.com
This episode was made in partnership with the Bay Area Global Health Alliance. You can find this episode and past epsiodes of A Shot in the Arm Podcast with Ben Plumley on these (and other) podcast platforms. Please subscribe and give us 5 stars!
Apple Podcasts - http://bit.ly/asita_apple
Google Podcasts - http://bit.ly/asita_google
Spotify - http://bit.ly/asita_spotify
iHeart Radio - http://bit.ly/asita_iheart
Stitcher - http://bit.ly/asita_stitcher
TuneIn (and Alexa enabled devices) - http://bit.ly/asita_tunein
Facebook: @shotarmpodcast - http://bit.ly/asita_fbvideos
YouTube: @shotarmpodcast - http://bit.ly/asita_youtube
--
#HIV, #SARSCoV2, #AIDS, #PrEP, #dolutegravir, #cabotegravir, #ViiV, #COVID19, #Coronavirus, #AIDS2020, #HIV2020, #TB, #InfectiousDisease, #PandemicsPreparation #Blacklivesmatter